Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

20
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Nature reviews. Nephrology·2018
Same author

Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay.

Blood·2018
Same author

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome.

Blood cancer journal·2018
Same author

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2018
Same author

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.

American journal of hematology·2018
Same author

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Nature reviews. Nephrology·2018

関連する実験動画

Updated: Sep 9, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.8K

軽鎖とトランスチレチンの心筋アミロイドと結果との関係

Izhan Hamza1, Shriya Bavishi2, Faysal Massad2

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN; Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
|September 3, 2025
PubMed
まとめ

心臓アミロイドーシス (CA) の種類は,エコーカルジオグラフィの特徴によって区別される. ストローク・ボリューム・インデックス (SVi) は独立してAL-CAとATTR-CAの死亡率を予測し,これらのCA疾患の予後モデルを改善します.

キーワード:
エコーカルディオグラフィーアミロイド心臓アミロイドーシス心臓画像検査心筋病

さらに関連する動画

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

13.5K
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.6K

関連する実験動画

Last Updated: Sep 9, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.8K
Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

13.5K
Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

11.6K

科学分野:

  • 心臓病科
  • 医療診断
  • 臨床研究

背景:

  • 心臓アミロイドーシス (CA) には,軽鎖 (AL-CA),野生型トランスチレチン (ATTRwt-CA),遺伝型トランスチレチン (ATTRv-CA) が含まれており,それぞれ独自の臨床経路と予後がある.
  • これらのCAサブタイプを区別することは,効果的な患者管理と治療戦略に不可欠です.

研究 の 目的:

  • AL-CA,ATTRwt-CA,ATTRv-CAを区別する独特のエコーカルディオグラフィの特徴を特定する.
  • これらのエコーカルディオグラフィの予測的意義,特に死亡率との関連を評価する.

主な方法:

  • 1968人の確定診断のCA患者を対象とした多部位コホート研究.
  • 診断時のエコーカルディオグラフィと臨床的変数を遡って比較する.
  • 死亡率の予測要因を特定するために,検証されたステージングシステムとコックス回帰を適用する.

主要な成果:

  • ATTRwt- CA患者は,AL- CA患者よりも年長で,男性の方が多く,併発症が多かった.
  • ATTR- CAサブタイプは,AL- CAと比較して左心室質量指数と低射出分子を示した.
  • ATTRwt- CAは左心房の体積指数と大動脈狭窄の有病率の増加と関連していました.
  • AL- CAとATTR- CAの両方で,脳卒中量指数 (SVi) は独立して死亡率と関連しており,予後モデルを向上させました.

結論:

  • 診断時に異なるエコーカルディオグラフィのサインが異なるタイプのCAを特徴付けます.
  • SViはCAにおける死亡率の重要な独立した予測因子であり,既存の予後段階測定システムの精度を向上させる.